Tomasz P. Radon
YOU?
Author Swipe
View article: Supplementary Figure 4 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 4 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Exploratory comparison of plasma CA19.9 and the urine biomarker panel in discriminating early pancreatic adenocarcinoma from chronic pancreatitis patients. A, ROC curves of the biomarker panel with corresponding plasma CA19.9 alone and in …
View article: Supplementary Figure 3 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 3 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Diagnostic performance of urine biomarkers in discriminating pancreatic adenocarcinoma all stages (A-C) and stage I-II (D-F) from chronic pancreatitis patients. A, ROC curves of PDAC (n=143) versus CP (n=62) patients for individual urine b…
View article: Supplementary Figure 6 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 6 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Expression of the protein biomarkers in pancreatic cancer tissues. A, Immunohistochemical analysis of REG1A: i) REG1A in poorly differentiated PDAC, ii) luminal REG1A in malignant glands. B, TFF1: i) heterogenous expression in cancer,, ii)…
View article: Supplementary Figure 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Urine proteome analysis. A, schematic outline of the study. B, classification of total identified proteins according to sub-cellular localisation and C, functional activity determined by Ingenuity Pathway Analysis. H: healthy, CP: chronic …
View article: Supplementary Figure 2 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 2 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Correlation of the three urinary biomarkers and plasma CA19.9 (CA19.9p). A, Correlation plots (Navy blue: Healthy; Turquoise: chronic pancreatitis (CP); Purple: pancreatic adenocarcinoma (PDAC). B, Pearson correlation coefficients and corr…
View article: Supplementary Figure 3 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 3 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Diagnostic performance of urine biomarkers in discriminating pancreatic adenocarcinoma all stages (A-C) and stage I-II (D-F) from chronic pancreatitis patients. A, ROC curves of PDAC (n=143) versus CP (n=62) patients for individual urine b…
View article: Supplementary Table 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Table 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Expression of non-redundant proteins identified by GeLC-MS/MS from males and females in healthy controls, chronic pancreatitis and pancreatic adenocarcinoma patients.
View article: Supplementary Figure 5 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 5 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Urine biomarker concentrations in different tumours. Scatter dot plots of urine LYVE1, REG1A and plasma CA19.9 in different hepatobiliary pathologies and early stages of pancreatic adenocarcinoma (I-IIA, n=16) and I-II (n=71). The level of…
View article: Supplementary Figure Legends from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure Legends from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Supplementary Figure Legends from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
View article: Data from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Data from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Purpose: Noninvasive biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) are currently not available. Here, we aimed to identify a set of urine proteins able to distinguish patients with early-stage PDAC from healthy …
View article: Supplementary Figure 5 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 5 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Urine biomarker concentrations in different tumours. Scatter dot plots of urine LYVE1, REG1A and plasma CA19.9 in different hepatobiliary pathologies and early stages of pancreatic adenocarcinoma (I-IIA, n=16) and I-II (n=71). The level of…
View article: Supplementary Figure 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Urine proteome analysis. A, schematic outline of the study. B, classification of total identified proteins according to sub-cellular localisation and C, functional activity determined by Ingenuity Pathway Analysis. H: healthy, CP: chronic …
View article: Supplementary Figure Legends from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure Legends from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Supplementary Figure Legends from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
View article: Data from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Data from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Purpose: Noninvasive biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) are currently not available. Here, we aimed to identify a set of urine proteins able to distinguish patients with early-stage PDAC from healthy …
View article: Supplementary Figure 4 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 4 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Exploratory comparison of plasma CA19.9 and the urine biomarker panel in discriminating early pancreatic adenocarcinoma from chronic pancreatitis patients. A, ROC curves of the biomarker panel with corresponding plasma CA19.9 alone and in …
View article: Supplementary Figure 6 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 6 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Expression of the protein biomarkers in pancreatic cancer tissues. A, Immunohistochemical analysis of REG1A: i) REG1A in poorly differentiated PDAC, ii) luminal REG1A in malignant glands. B, TFF1: i) heterogenous expression in cancer,, ii)…
View article: Supplementary Figure 2 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Figure 2 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Correlation of the three urinary biomarkers and plasma CA19.9 (CA19.9p). A, Correlation plots (Navy blue: Healthy; Turquoise: chronic pancreatitis (CP); Purple: pancreatic adenocarcinoma (PDAC). B, Pearson correlation coefficients and corr…
View article: Supplementary Table 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Supplementary Table 1 from Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Expression of non-redundant proteins identified by GeLC-MS/MS from males and females in healthy controls, chronic pancreatitis and pancreatic adenocarcinoma patients.
View article: AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting
AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting Open
Anterior gradient 2 (AGR2), a protein disulfide isomerase, shows two subcellular localizations: intracellular (iAGR2) and extracellular (eAGR2). In healthy cells that express AGR2, the predominant form is iAGR2, which resides in the endopl…
View article: Perineural invasion in pancreatic cancer: proteomic analysis and <i>in vitro</i> modelling
Perineural invasion in pancreatic cancer: proteomic analysis and <i>in vitro</i> modelling Open
Perineural invasion ( PNI ) is a common and characteristic feature of pancreatic ductal adenocarcinoma ( PDAC ) that is associated with poor prognosis, tumor recurrence, and generation of pain. However, the molecular alterations in cancer …
View article: The life and works of S100P - from conception to cancer.
The life and works of S100P - from conception to cancer. Open
Since its discovery in 1992, the small, 10.4 kDa calcium-binding protein S100P has gained the attention of researchers from different scientific fields due to its potential roles in both healthy and neoplastic tissues. Although not ubiquit…
View article: Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Open
Purpose: Noninvasive biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) are currently not available. Here, we aimed to identify a set of urine proteins able to distinguish patients with early-stage PDAC from healthy …
View article: Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma.
Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma. Open
Currently, the majority of patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) present with locally invasive and/or metastatic disease, resulting in five-year survival of less than 5%. The development of an early diagnostic tes…